Years before tau tangles show up in brain scans of patients with Alzheimer's disease, a biomarker test developed at the ...
Scientists develop groundbreaking dual-action drug RI-AG03 that targets toxic tau proteins in Alzheimer's disease, showing ...
A recent study published in eLife offers a new perspective on the development of Alzheimer’s disease, suggesting that the ...
A research team has discovered that the two key pathological hallmarks of Alzheimer's -- tau protein and beta-amyloid -- affect brain circuits in distinct yet synergistic ways, particularly those ...
Small amount of the protein found in those with Alzheimer’s disease can be detected years before it shows up in brain scans ...
It's common among people, like Walsh, who have Alzheimer's disease. For his wife, Karen, it was the first sign that something could be seriously wrong. "He was struggling to find words to complete the ...
In a bid to revolutionize Alzheimer’s detection, scientists have examined the brain’s neurovascular unit. The research ...
Research led by Lancaster University has revealed clear evidence that changes in the orchestration of brain oxygenation dynamics and neuronal function in Alzheimer's disease contribute to the ...
Scientists have used advanced X-ray phase-contrast tomography (XPCT) to uncover how gut health may influence Alzheimer’s disease.
SaveHealth provides an overview of Alzheimer's disease, including treatment and coping mechanisms for those with the disease ...
Explore the potential of monoclonal antibodies in Alzheimer’s treatment, including breakthroughs and challenges in this ...
Years before tau tangles show up in brain scans of patients with Alzheimer's disease, a biomarker test developed at the ...